Quantification of matrix metalloproteinases and tissue inhibitors of metalloproteinase in prostatic tissue: Analytical aspects

Prostate

Volumn 34, Issue 2, 1998, Pages 130-136

  Jung, Klaus ^a   Lein, Michael ^a   Ulbrich, Norbert ^b   Rudolph, Birgit ^a   Henke, Wolfgang ^a   Schnorr, Dietmar ^a   Loening, Stefan A ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b German Center for Rheumatology Research   (Germany)

Author keywords

Matrix metalloproteinase; Prostate; Prostate carcinoma; Tissue inhibitor of metalloproteinase

Indexed keywords

CALCIUM CHLORIDE; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE; TRITON X 100;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EXTRACTION; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSTATE CANCER;

EID: 0031939426     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19980201)34:2<130::AID-PROS8>3.0.CO;2-O     Document Type: Article

References (39)

1. Liotta LA, Stetler Stevenson WG: Tumor invasion and metastasis: An imbalance of positive and negative regulation. Cancer Res [Suppl] 1991;51:5054-5059.
2. Crawford HC, Matrisian LM: Tumor and stromal expression of matrix metalloproteinases and their role in tumor progression. Invasion Metastasis 1995;14:234-245.
3. Anderson IC, Sugarbaker DJ, Ganju RK, Tsarwhas DG, Richards WG, Sunday M, Kobzik L, Shipp MA: Stromelysin-3 is overexpressed by stromal elements in primary non-small cell lung cancers and regulated by retinoic acid in pulmonary fibroblasts. Cancer Res 1995;55:4120-4126.
4. Murray GI, Duncan ME, O'Neil P, Melvin WT, Fothergill JE: Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nat Med 1996;2:461-462.
5. Davies B, Miles DW, Happerfield LC, Naylor MS, Bobrow LG, Rubens RD, Balkwill FR: Activity of type IV collagenases in benign and malignant breast disease. Br J Cancer 1993;67:1126-1131.
6. Yamagata S, Yoshii Y, Suh JG, Tanaka R, Shimizu S: Occurrence of an active form of gelatinase in human gastric and colorectal carcinoma tissues. Cancer Lett 1991;59:51-55.
7. Tsuchiya Y, Sato H, Endo Y, Okada Y, Mai M, Sasaki T, Seiki M: Tissue inhibitor of metalloproteinase 1 is a negative regulator of the metastatic ability of a human gastric cancer cell line, KKLS, in the chick embryo. Cancer Res 1993;53:1397-1402.
8. Testa JE: Loss of the metastatic phenotype by a human epidermoid carcinoma cell line, HEp-3, is accompanied by increased expression of tissue inhibitor of metalloproteinase 2. Cancer Res 1992;52:5597-5603.
9. Stearns ME, Wang M: Type IV collagenase (M(r) 72,000) expression in human prostate: Benign and malignant tissue. Cancer Res 1993;53:878-883.
10. Pajouh MS, Nagle RB, Breathnach R, Finch JS, Brawer MK, Bowden GT: Expression of metalloproteinase genes in human prostate cancer. J Cancer Res Clin Oncol 1991;117:144-150.
11. Hamdy FC, Fadlon EJ, Cottam D, Lawry J, Thurrell W, Silcocks PB, Anderson JB, Williams JL, Rees RC: Matrix metalloproteinase 9 expression in primary human prostatic adenocarcinoma and benign prostatic hyperplasia. Br J Cancer 1994;69:177-182.
12. Stearns M, Stearns ME: Evidence for increased activated metalloproteinase 2 (MMP-2a) expression associated with human prostate cancer progression. Oncol Res 1996;8:69-75.
13. Stearns ME, Stearns M: Immunohistochemical studies of activated metalloproteinase-2 (MMP-2a) expression in human prostate cancer. Oncol Res 1996;8:63-67.
14. Stetler Stevenson WG, Hewitt R, Corcoran M: Matrix metalloproteinases and tumor invasion: From correlation and causality to the clinic. Semin Cancer Biol 1996,7:147-154.
15. Woessner JF: Quantification of matrix metalloproteinases in tissue samples. In Barrett AJ (ed): "Proteolytic Enzymes: Aspartic and Metallopeptidases," San Diego: Academic Press, 1995:510-528.
16. Irimura T, Yamori T, Bennett SC, Ota DM, Cleary KR: The relationship of collagenolytic activity to stage of human colorectal carcinoma. Int J Cancer 1987;40:24-31.
17. Lu XQ, Levy M, Weinstein IB, Santella RM: Immunological quantitation of levels of tissue inhibitor of metalloproteinase-1 in human colon cancer. Cancer Res 1991;51:6231-6235.
18. Tokuraku M, Sato H, Murakami S, Okada Y, Watanabe Y, Seiki M: Activation of the precursor of gelatinase A/72 kDa type IV collagenase/MMP-2 in lung carcinomas correlates with the expression of membrane-type matrix metalloproteinase (MT-MMP) and with lymph node metastasis. Int J Cancer 1995;64: 355-359.
19. Benyon RC, Iredale JP, Goddard S, Winwood PJ, Arthur MJP: Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver. Gastroenterology 1996;110: 821-831.
20. Sier CFM, Kubben FJGM, Ganesh S, Heerding MM, Griffioen G, Hanemaaijer R, Van Krieken JHJM, Lamers CBHW, Verspaget HW: Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma. Br J Cancer 1996;74:413-417.
21. Tyagi SC, Kumar SG, Banks J, Fortson W: Co-expression of tissue inhibitor and matrix metalloproteinase in myocardium. J Mol Cell Cardiol 1996;27:2177-2189.
22. Daneri Navarro A, Del Toro Arreola S, Bravo Cuellar A, Cabrera N, Orbach Arbouys S, Perez Montfort R: Proteolytic activity in extracts of invasive cervical carcinoma and precursor lesions. Biomed Pharmacother 1995;49:304-310.
23. Peehl DM: Culture of human prostatic epithelial cells. In Freshney RI (ed): "Culture of Epithelial Cells," New York: Wiley-Liss, 1992:159-180.
24. Knight CG, Willenbrock F, Murphy G: A novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases. FEBS Lett 1992;296:263-266.
25. Dunn MJ: Determination of total protein concentration. In Harris ELV, Angal S (eds): "Protein Purification Methods," Oxford: IRL Press, 1992:10-18.
26. Dean DD, Martel Pelletier J, Pelletier JP, Howell DS, Woessner JF: Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J Clin Invest 1989;84:678-685.
27. Zhu C, Woessner JF: A tissue inhibitor of metalloproteinases and alpha-macroglobulins in the ovulating rat ovary: Possible regulators of collagen matrix breakdown. Biol Reprod 1991;45: 334-342.
28. Knox JD, Wolf C, McDaniel K, Clark V, Loriot M, Bowden GT, Nagle RB: Matrilysin expression in human prostate carcinoma. Mol Carcinog 1996;15:57-63.
29. Boag AH, Young ID: Immunohistochemical analysis of type IV collagenase expression in prostatic hyperplasia and adenocarcinoma. Mod Pathol 1993;6:65-68.
30. Stearns M, Wang M, Stearns ME: Cytokine (IL-10, IL-6) induction of tissue inhibitor of metalloproteinase 1 in primary human prostate tumor cell lines. Oncol Res 1995;7:173-181.
31. Stearns ME, Wang M: Immunoassays of the metalloproteinase (MMP-2) and tissue inhibitor of metalloproteinase (TIMP 1 and 2) levels in noninvasive and metastatic PC-3 clones: Effects of taxol. Oncol Res 1994;6:195-201.
32. Wilson MJ, Sinha AA: Plaminogen activator and metalloprotease activities of DU-145, PC-3, and 1-LN-PC-3-1a human prostate tumors grown in nude mice: Correlation with tumor invasive behavior. Cell Mol Biol Res 1993;39:751-760.
33. Wilson MJ, Kapoor S, Vogel MM, Sinha AA: Characterization of gelatin-degrading metalloproteinase activities of the Dunning rat prostate tumor grown in nude mice. Prostate 1991;19:237-250.
34. Wilson MJ: Proteases in prostate development, function, and pathology. Microsc Res Tech 1995;30:305-318.
35. Lokeshwar BL, Selzer MG, Block NL, Gunja-Smith Z: Secretion of matrix metalloproteinases and their inhibitors (tissue inhibitor of metalloproteinases) by human prostate explant cultures: Reduced tissue inhibitor of metalloproteinase secretion by malignant tissues. Cancer Res 1993;53:4493-4498.
36. Hayakawa T, Yamashita K, Tanzawa K, Uchijima E, Iwata K: Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum. FEBS Lett 1992;298:29-32.
37. Kikuchi K, Kubo M, Sato S, Fujimoto M, Tamaki K: Serum tissue inhibitor of metalloproteinases in patients with systemic sclerosis. J Am Acad Dermatol 1995;33:973-978.
38. Zeng ZS, Cohen AM, Zhang ZF, Stetler Stevenson WG, Guillem JG: Elevated tissue inhibitor of metalloproteinase 1 RNA in colorectal cancer stroma correlates with lymph node and distant metastases. Clin Cancer Res 1995;1:899-906.
39. Bramhall SR, Stamp GW, Dunn J, Lemoine NR, Neoptolemos JP: Expression of collagenase (MMP2), stromelysin (MMP3) and tissue inhibitor of the metalloproteinases (TIMP1) in pancreatic and ampullary disease. Br J Cancer 1996;73:972-978.